Tag Archives: Vanessa’s Law
Enacting Pharmaceutical Transparency – Who, What, How, When, & Why
Matthew Herder shares a template letter that physicians, researchers, civil society groups, investigative journalists, and others can use to gain access to unpublished pharmaceutical safety and effectiveness data.
Testing Canada’s New Pharmaceutical Transparency Law
Matthew Herder and Trudo Lemmens explore the ways that Canada’s transparency legislation may limit researchers’ abilities to scrutinize drug safety and effectiveness.
The Opacity of Bill C-17’s Transparency Amendments
Matthew Herder says it is unclear whether the ‘Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law)’ will provide greater transparency in Canadian drug regulation.
Regulating Prescription Drugs @ The Limits of Legal Authority
Matthew Herder explains why Health Canada’s “life cycle” approach to drug regulation may be beyond the regulator’s mandate.
Impact Ethics 